论文部分内容阅读
目的:观察氨溴特罗口服液辅助治疗小儿支气管肺炎的临床疗效。方法:将2012年1月至2013年12月在广州新医院儿科收治的支气管肺炎患儿200例,随机分为治疗组100例和对照组100例。两组均采用抗感染、止咳、祛痰、雾化及平喘等治疗。治疗组加用氨溴特罗口服液,比较两组疗效。结果:治疗组较对照组主要临床症状、体征消失时间,住院天数均显著优于对照组,两组疗效比较差异有统计学意义(P<0.05)。结论:氨溴特罗口服液治疗小儿支气管肺炎疗效显著,安全性高,应用方便。
Objective: To observe the clinical efficacy of ambroxol oral solution in the treatment of bronchial pneumonia in children. Methods: From January 2012 to December 2013, 200 children with bronchial pneumonia treated in pediatric department of Guangzhou New Hospital were randomly divided into treatment group (100 cases) and control group (100 cases). Both groups used anti-infective, cough, expectorant, nebulization and antiasthmatic treatment. The treatment group plus ambroxol oral solution, the two groups were compared. Results: Compared with the control group, the main clinical symptoms, signs of disappearance and days of hospitalization in the treatment group were significantly better than those in the control group. There was significant difference between the two groups (P <0.05). Conclusion: Ambroxol oral solution in children with bronchopneumonia has significant curative effect, high safety and convenient application.